Insights On Partnering

  1. 5 Projections For 2026: Navigating The New Normal In Clinical Trials 2/18/2026

    In 2026, clinical trial success depends on moving from AI hype to proven utility. Unified data and seamless site experiences are no longer optional; they are the keys to trial resilience.

  2. Four Pivotal Categories To Elevate Your Clinical Vendor Management 8/22/2025

    For sponsors ready to improve vendor management, technology platforms with the right framework can help you tighten budget controls, improve data integrity, or foster collaborative vendor relationships.

  3. Debunking Five Misconceptions About Community-Based Research Sites 5/28/2025

    By confronting misconceptions about community-based research, we uncover evidence of how sites effectively manage complex trials while maintaining high standards of care.

  4. Planning For High-Performance Hematologic Oncology Clinical Trials 5/7/2024

    Running successful clinical trials in hematologic malignancies necessitates a deep comprehension of a swiftly evolving treatment framework that is growing more nuanced, intricate, and patient-centered.

  5. Insights From Facilitating Over A Billion Dollars In Vendor Contracts 7/1/2025

    By transforming vendor selection from a manual task into a data-driven, strategic process, sponsors can build stronger, more effective clinical trial teams.

  6. Pay-By-Procedure Vs. Pay-By-Visit 12/8/2025

    Explore how a pay-by-procedure model can reshape site payments, enhance transparency, and reveal meaningful efficiencies across complex clinical trials.

  7. CRO Solutions Expo: Clinical Research Is A Delicate Ecosystem 11/21/2025

    Elevate your complex oncology program by partnering with a team that delivers transparent communication, deep expertise, and the focused attention emerging and midsized biotechs need to succeed.

  8. The Case For Parallel Processing In Clinical Trial Start-Up 1/26/2026

    Stop letting outdated processes stall your innovation and learn how parallel processing transforms study start-up from a series of hurdles into a synchronized sprint.

  9. Why Bioanalysis Needs To Break Free From Manual Bottlenecks 9/2/2025

    Bioanalysis remains one of the most persistent bottlenecks in drug development, with CROs displaying inefficiencies that are no longer operational nuisances but strategic liabilities.

  10. The Next Frontier In Early Phase Oncology Trials 10/18/2024

    This session explores the pivotal role of First-in-Human and early phase oncology trials in drug development, emphasizing the importance of comprehensive planning for successful execution.